SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-212576
Filing Date
2023-08-15
Accepted
2023-08-14 18:05:18
Documents
11

Document Format Files

Seq Description Document Type Size
1 S-3 d764599ds3.htm S-3 268103
2 EX-4.5 d764599dex45.htm EX-4.5 365136
3 EX-4.6 d764599dex46.htm EX-4.6 390243
4 EX-5.1 d764599dex51.htm EX-5.1 26285
5 EX-23.1 d764599dex231.htm EX-23.1 1594
6 EX-23.2 d764599dex232.htm EX-23.2 1541
7 EX-FILING FEES d764599dexfilingfees.htm EX-FILING FEES 33689
8 GRAPHIC g764599g0815001707238.jpg GRAPHIC 6687
9 GRAPHIC g764599g0815001707478.jpg GRAPHIC 23831
10 GRAPHIC g764599g0815001707613.jpg GRAPHIC 21344
11 GRAPHIC g764599g21a77.jpg GRAPHIC 2170
  Complete submission text file 0001193125-23-212576.txt   1162601
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-273984 | Film No.: 231172454
SIC: 2834 Pharmaceutical Preparations